Improving human sperm motility via red and near-infrared laser irradiation: in-vitro study.
Rasha AhmedOmnia HamdyShaimaa ElattarAmany Ahmed SolimanPublished in: Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology (2024)
Improved sperm motility is necessary for successful sperm passage through the female genital system, efficacious fertilization, and a greater probability of pregnancy. By stimulating the mitochondrial respiratory chain, low-level laser photobiomodulation has been shown to increase sperm motility and velocity. The respiratory chain in mitochondria is the primary site of action for cytochrome c oxidase because it can absorb light in the visible and infrared ranges. The present study aimed to investigate the effects of red laser 650 nm, near infrared laser (NIR) 980 nm, and combination of both on human spermatozoa motility and DNA integrity at different doses. An in-vitro controlled trial was performed in Al Zahraa university hospital laboratory using thirty fresh human semen specimens. Samples were exposed to red laser 650 nm, near infrared laser (NIR) 980 nm, and combination of both for various irradiation times. Sperm motility for the test and control aliquots was assessed as recommended in the manual of WHO-2021. Sperm chromatin integrity was evaluated using the Sperm Chromatin Structure Assay. Results revealed almost 70%, 80% and 100% increase in the total motility after 3 min of the 650-nm, 980-nm and the combined laser irradiation, respectively. Additionally, the Sperm Chromatin Dispersion assay was carried out on sperm heads utilizing human sperm DNA fragmentation, demonstrating that none of the three laser types had any discernible effects.
Keyphrases
- photodynamic therapy
- endothelial cells
- biofilm formation
- high speed
- gene expression
- induced pluripotent stem cells
- dna damage
- transcription factor
- genome wide
- radiation therapy
- high throughput
- oxidative stress
- clinical trial
- circulating tumor
- single molecule
- study protocol
- fluorescence imaging
- open label
- reactive oxygen species
- drug release
- pregnancy outcomes